Annual Shareholders Equity
$7.48 M
-$4.26 M-36.29%
December 31, 2023
Summary
- As of February 7, 2025, GTBP annual stockholders equity is $7.48 million, with the most recent change of -$4.26 million (-36.29%) on December 31, 2023.
- During the last 3 years, GTBP annual shareholders equity has risen by +$36.91 million (+125.40%).
- GTBP annual shareholders equity is now -97.03% below its all-time high of $251.86 million, reached on December 31, 2017.
Performance
GTBP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$2.10 M
-$3.41 M-61.93%
September 30, 2024
Summary
- As of February 7, 2025, GTBP quarterly stockholders equity is $2.10 million, with the most recent change of -$3.41 million (-61.93%) on September 30, 2024.
- Over the past year, GTBP quarterly shareholders equity has dropped by -$3.21 million (-60.52%).
- GTBP quarterly shareholders equity is now -99.17% below its all-time high of $253.89 million, reached on September 30, 2017.
Performance
GTBP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
GTBP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.3% | -60.5% |
| 3 y3 years | +125.4% | -83.9% |
| 5 y5 years | -35.2% | -83.9% |
GTBP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.9% | at low | -90.4% | at low |
| 5 y | 5-year | -65.9% | +125.4% | -94.3% | +107.1% |
| alltime | all time | -97.0% | +114.8% | -99.2% | +104.2% |
GT Biopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.10 M(-61.9%) |
| Jun 2024 | - | $5.51 M(+3.7%) |
| Mar 2024 | - | $5.31 M(-28.9%) |
| Dec 2023 | $7.48 M(-36.3%) | $7.48 M(-25.3%) |
| Sep 2023 | - | $10.01 M(-14.9%) |
| Jun 2023 | - | $11.76 M(-9.9%) |
| Mar 2023 | - | $13.05 M(+11.2%) |
| Dec 2022 | $11.73 M(-46.4%) | $11.73 M(-26.5%) |
| Sep 2022 | - | $15.95 M(+3.3%) |
| Jun 2022 | - | $15.44 M(-13.2%) |
| Mar 2022 | - | $17.79 M(-18.8%) |
| Dec 2021 | $21.91 M(-174.4%) | $21.91 M(-31.6%) |
| Sep 2021 | - | $32.05 M(-12.1%) |
| Jun 2021 | - | $36.46 M(+50.7%) |
| Mar 2021 | - | $24.19 M(-182.2%) |
| Dec 2020 | -$29.43 M(+53.8%) | -$29.43 M(-0.6%) |
| Sep 2020 | - | -$29.61 M(+8.3%) |
| Jun 2020 | - | -$27.33 M(+32.1%) |
| Mar 2020 | - | -$20.69 M(+8.1%) |
| Dec 2019 | -$19.14 M(-265.9%) | -$19.14 M(+5.7%) |
| Sep 2019 | - | -$18.12 M(-298.1%) |
| Jun 2019 | - | $9.14 M(-10.2%) |
| Mar 2019 | - | $10.19 M(-11.7%) |
| Dec 2018 | $11.54 M(-95.4%) | $11.54 M(-14.4%) |
| Sep 2018 | - | $13.48 M(-94.5%) |
| Jun 2018 | - | $246.23 M(-2.5%) |
| Mar 2018 | - | $252.43 M(+0.2%) |
| Dec 2017 | $251.86 M(-1442.9%) | $251.86 M(-0.8%) |
| Sep 2017 | - | $253.89 M(-1374.9%) |
| Jun 2017 | - | -$19.91 M(+11.0%) |
| Mar 2017 | - | -$17.94 M(-4.3%) |
| Dec 2016 | -$18.75 M(-62.8%) | -$18.75 M(+10.1%) |
| Sep 2016 | - | -$17.04 M(+8.8%) |
| Jun 2016 | - | -$15.66 M(-21.9%) |
| Mar 2016 | - | -$20.05 M(-60.2%) |
| Dec 2015 | -$50.40 M(+71.4%) | -$50.40 M(+106.7%) |
| Sep 2015 | - | -$24.38 M(+7.3%) |
| Jun 2015 | - | -$22.73 M(-54.3%) |
| Mar 2015 | - | -$49.76 M(+69.2%) |
| Dec 2014 | -$29.41 M(+375.7%) | -$29.41 M(+173.4%) |
| Sep 2014 | - | -$10.75 M(+57.8%) |
| Jun 2014 | - | -$6.81 M(+4.0%) |
| Mar 2014 | - | -$6.55 M(+6.0%) |
| Dec 2013 | -$6.18 M(-1.0%) | -$6.18 M(+6.1%) |
| Sep 2013 | - | -$5.83 M(+5.6%) |
| Jun 2013 | - | -$5.52 M(+5.9%) |
| Mar 2013 | - | -$5.21 M(-16.5%) |
| Dec 2012 | -$6.25 M(+22.4%) | -$6.25 M(+2.2%) |
| Sep 2012 | - | -$6.11 M(-4.8%) |
| Jun 2012 | - | -$6.42 M(+22.0%) |
| Mar 2012 | - | -$5.26 M(+3.2%) |
| Dec 2011 | -$5.10 M(-6.7%) | -$5.10 M(+4.0%) |
| Sep 2011 | - | -$4.91 M(-11.9%) |
| Jun 2011 | - | -$5.57 M(-20.7%) |
| Mar 2011 | - | -$7.02 M(+28.4%) |
| Dec 2010 | -$5.47 M(-4.5%) | -$5.47 M(+3.9%) |
| Sep 2010 | - | -$5.26 M(-4.2%) |
| Jun 2010 | - | -$5.50 M(-22.8%) |
| Mar 2010 | - | -$7.12 M(+24.3%) |
| Dec 2009 | -$5.72 M(+55.5%) | -$5.72 M(+24.7%) |
| Sep 2009 | - | -$4.59 M(+6.2%) |
| Jun 2009 | - | -$4.32 M(+9.0%) |
| Mar 2009 | - | -$3.97 M(+7.8%) |
| Dec 2008 | -$3.68 M(-582.3%) | -$3.68 M(+3.3%) |
| Sep 2008 | - | -$3.56 M(+28.8%) |
| Jun 2008 | - | -$2.77 M(+1082.5%) |
| Mar 2008 | - | -$234.00 K(-130.7%) |
| Dec 2007 | $763.00 K(-232.7%) | $763.00 K(+72.6%) |
| Sep 2007 | - | $442.00 K(+1281.3%) |
| Jun 2007 | - | $32.00 K(-102.9%) |
| Mar 2007 | - | -$1.12 M(+95.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | -$575.00 K(-119.6%) | -$575.00 K(-137.9%) |
| Sep 2006 | - | $1.52 M(-20.4%) |
| Jun 2006 | - | $1.91 M(-18.4%) |
| Mar 2006 | - | $2.34 M(-20.3%) |
| Dec 2005 | $2.93 M(-49.4%) | $2.93 M(-43.2%) |
| Sep 2005 | - | $5.16 M(-5.8%) |
| Jun 2005 | - | $5.48 M(-4.6%) |
| Mar 2005 | - | $5.75 M(-0.9%) |
| Dec 2004 | $5.80 M(+566.2%) | $5.80 M(-2025.6%) |
| Sep 2004 | - | -$301.00 K(+7.5%) |
| Jun 2004 | - | -$280.00 K(-132.5%) |
| Mar 2004 | - | $862.00 K(-0.9%) |
| Dec 2003 | $870.00 K(-28.6%) | $870.00 K(-3.7%) |
| Sep 2003 | - | $903.00 K(+10.7%) |
| Jun 2003 | - | $816.00 K(-24.0%) |
| Mar 2003 | - | $1.07 M(-11.8%) |
| Dec 2002 | $1.22 M(+128.5%) | $1.22 M(-12.2%) |
| Sep 2002 | - | $1.39 M(-16.9%) |
| Jun 2002 | - | $1.67 M(-9.1%) |
| Mar 2002 | - | $1.84 M(+244.5%) |
| Dec 2001 | $533.00 K(-86.9%) | $533.00 K(-32.0%) |
| Sep 2001 | - | $784.00 K(-31.2%) |
| Jun 2001 | - | $1.14 M(-61.2%) |
| Mar 2001 | - | $2.94 M(-27.9%) |
| Dec 2000 | $4.07 M(+51.5%) | $4.07 M(-26.3%) |
| Sep 2000 | - | $5.53 M(-17.1%) |
| Jun 2000 | - | $6.67 M(+4.8%) |
| Mar 2000 | - | $6.36 M(+136.6%) |
| Dec 1999 | $2.69 M(-62.6%) | $2.69 M(-13.3%) |
| Sep 1999 | - | $3.10 M(-26.2%) |
| Jun 1999 | - | $4.20 M(-30.0%) |
| Mar 1999 | - | $6.00 M(-16.6%) |
| Dec 1998 | $7.20 M(+5.8%) | $7.20 M(-21.8%) |
| Sep 1998 | - | $9.20 M(+4.5%) |
| Jun 1998 | - | $8.80 M(+79.6%) |
| Mar 1998 | - | $4.90 M(-27.9%) |
| Dec 1997 | $6.80 M(+51.1%) | $6.80 M(+9.7%) |
| Sep 1997 | - | $6.20 M(-18.4%) |
| Jun 1997 | - | $7.60 M(+145.2%) |
| Mar 1997 | - | $3.10 M(-31.1%) |
| Dec 1996 | $4.50 M(+4.7%) | $4.50 M(-11.8%) |
| Sep 1996 | - | $5.10 M(-22.7%) |
| Jun 1996 | - | $6.60 M(+88.6%) |
| Mar 1996 | - | $3.50 M(-18.6%) |
| Dec 1995 | $4.30 M(-35.8%) | $4.30 M(-29.5%) |
| Sep 1995 | - | $6.10 M(-1.6%) |
| Jun 1995 | - | $6.20 M(-3.1%) |
| Mar 1995 | - | $6.40 M(-4.5%) |
| Dec 1994 | $6.70 M(+139.3%) | $6.70 M(-11.8%) |
| Sep 1994 | - | $7.60 M(+216.7%) |
| Jun 1994 | - | $2.40 M(-7.7%) |
| Mar 1994 | - | $2.60 M(-7.1%) |
| Dec 1993 | $2.80 M(-34.9%) | $2.80 M(-3.4%) |
| Sep 1993 | - | $2.90 M(-12.1%) |
| Jun 1993 | - | $3.30 M(-23.3%) |
| Mar 1993 | - | $4.30 M(0.0%) |
| Dec 1992 | $4.30 M(-6.5%) | $4.30 M(-4.4%) |
| Sep 1992 | - | $4.50 M(-2.2%) |
| Jun 1992 | - | $4.60 M(+2.2%) |
| Mar 1992 | - | $4.50 M(-2.2%) |
| Dec 1991 | $4.60 M(-4.2%) | $4.60 M(-2.1%) |
| Sep 1991 | - | $4.70 M(-2.1%) |
| Dec 1990 | $4.80 M(+23.1%) | $4.80 M(+23.1%) |
| Dec 1989 | $3.90 M(+21.9%) | $3.90 M(+21.9%) |
| Dec 1988 | $3.20 M(+3.2%) | $3.20 M(+3.2%) |
| Dec 1987 | $3.10 M(+10.7%) | $3.10 M(+10.7%) |
| Dec 1986 | $2.80 M(-9.7%) | $2.80 M(-9.7%) |
| Dec 1985 | $3.10 M(-11.4%) | $3.10 M(-11.4%) |
| Dec 1984 | $3.50 M(+2.9%) | - |
| Dec 1984 | - | $3.50 M |
| Feb 1984 | $3.40 M | - |
FAQ
- What is GT Biopharma annual stockholders equity?
- What is the all time high annual shareholders equity for GT Biopharma?
- What is GT Biopharma annual shareholders equity year-on-year change?
- What is GT Biopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for GT Biopharma?
- What is GT Biopharma quarterly shareholders equity year-on-year change?
What is GT Biopharma annual stockholders equity?
The current annual shareholders equity of GTBP is $7.48 M
What is the all time high annual shareholders equity for GT Biopharma?
GT Biopharma all-time high annual stockholders equity is $251.86 M
What is GT Biopharma annual shareholders equity year-on-year change?
Over the past year, GTBP annual stockholders equity has changed by -$4.26 M (-36.29%)
What is GT Biopharma quarterly stockholders equity?
The current quarterly shareholders equity of GTBP is $2.10 M
What is the all time high quarterly shareholders equity for GT Biopharma?
GT Biopharma all-time high quarterly stockholders equity is $253.89 M
What is GT Biopharma quarterly shareholders equity year-on-year change?
Over the past year, GTBP quarterly stockholders equity has changed by -$3.21 M (-60.52%)